iANTHUS CAPITAL HOLDINGS (ITHUF) Asset Writedowns and Impairment (2020 - 2022)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Asset Writedowns and Impairment came in at $2.7 million in Q4 2022, down 51.53% year-on-year from $5.5 million in Q4 2021, and down 51.53% quarter-over-quarter from $5.5 million in Q4 2021.
iANTHUS CAPITAL HOLDINGS (ITHUF) Asset Writedowns and Impairment (2020 - 2022) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $2.7 million for Q4 2022.
- Asset Writedowns and Impairment for Q4 2022 came in at $2.7 million, down 51.53% year-over-year; the trailing twelve-month figure through Dec 2022 was $8.2 million (up 11.73% YoY), and the FY2022 annual result was $2.7 million, down 63.53% from the prior year.
- Asset Writedowns and Impairment came in at $2.7 million for Q4 2022 at iANTHUS CAPITAL HOLDINGS, down from $5.5 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $199.4 million in Q1 2020 to a low of $127000.0 in Q3 2021.
- The 3-year median for Asset Writedowns and Impairment is $3.4 million (2020), against an average of $35.6 million.
- Across the five-year window, Asset Writedowns and Impairment slumped 96.9% in 2021 and slumped 51.53% in 2022, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Asset Writedowns and Impairment stood at $4.1 million in 2020, then jumped by 35.22% to $5.5 million in 2021, then plunged by 51.53% to $2.7 million in 2022.
- The last three Asset Writedowns and Impairment figures came in at $2.7 million (Q4 2022), $5.5 million (Q4 2021), and $127000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.69 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Dec 31, 2021 | 5.54 Mn |
| Dec 31, 2021 | 5.54 Mn |
| Sep 30, 2021 | 127,000.00 |
| Sep 30, 2021 | 127,000.00 |
| Jun 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 1.70 Mn |
| Sep 30, 2020 | 4.10 Mn |
| Sep 30, 2020 | 4.10 Mn |
| Mar 31, 2020 | 199.36 Mn |
| Mar 31, 2020 | 199.36 Mn |